![[Leu31,Pro34]-NeuropeptideY (human,rat) <span class="caps">CAS</span> <span class="caps">PNA-0215</span>](https://www.watson-int.com/wp-content/uploads/2025/03/no-image.png)
[Leu31,Pro34]-NeuropeptideY (human,rat) CAS PNA-0215
[Leu31,Pro34]-NeuropeptideY
(human,rat),PNA-0215,Tyr-Pro-Ser-Lys-Pro-Asp-Asn-
Pro-Gly-Glu-Asp-Ala-Pro-Ala-
Glu-Asp-Met-Ala-Arg-Tyr-Tyr-
Ser-Ala-Leu-Arg-His-Tyr-Ile-
Asn-Leu-Leu-Thr-Arg-Pro-Arg-
Tyr-NH2,C190H286N54O56




![Structure of Ferrocene, 1-(diphenylphosphino)-2-[(<span class="caps">1R</span>)-1-[[2-[[(<span class="caps">1R</span>)-1-(hydroxymethyl)-2,2-dimethylpropyl]amino]-2-oxoethyl]amino]ethyl]-, (<span class="caps">1R</span>)- <span class="caps">CAS</span> 2922459-71-8 Structure of Ferrocene, 1-(diphenylphosphino)-2-[(1R)-1-[[2-[[(1R)-1-(hydroxymethyl)-2,2-dimethylpropyl]amino]-2-oxoethyl]amino]ethyl]-, (1R)- CAS 2922459-71-8](https://www.watson-int.com/wp-content/uploads/2025/10/Structure-of-Ferrocene-1-diphenylphosphino-2-1R-1-2-1R-1-hydroxymethyl-22-dimethylpropylamino-2-oxoethylaminoethyl-1R-CAS-2922459-71-8.png)




